Clinical manifestations of atherosclerosis in an elderly population are related to plasma neopterin, NGAL and endothelin-1, but not to Chlamydia pneumoniae serology

International Angiology

Volumn 21, Issue 2, 2002, Pages 173-179

  Forsblad, J ^a   Gottsater A ^a   Persson, K ^a   Jacobsson, L ^a   Lindgarde F ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aged; Atherosclerosis; Chlamydia; Inflammation

Indexed keywords

AUTACOID; CYCLIC AMP; ENDOTHELIN 1; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; GELATINASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LIPOCALIN; NEOPTERIN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AGE; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LEUKOCYTE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; NEUTROPHIL; POPULATION RESEARCH; PREDICTION; PROSPECTIVE STUDY; SEROLOGY; THROMBOCYTE;

ACUTE-PHASE PROTEINS; AGED; ARTERIOSCLEROSIS; CARRIER PROTEINS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CROSS-SECTIONAL STUDIES; CYCLIC AMP; CYCLIC GMP; ENDOTHELIN-1; FEMALE; HUMANS; LOGISTIC MODELS; MALE; NEOPTERIN; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS;

EID: 0036620053     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med 1999;340:115-26.
2. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199-204.
3. Danesh J, Collins R, Appleby P, Peto R. C-reactive protein, albumin or white cell count: meta-analyses of prospective studies of coronary heart disease. JAMA 1998;279:1477-82.
4. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
5. Vallance P, Collier J, Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet 1997;349:1391-2.
6. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis. Circulation 1997;96:4095-103.
7. Saikku P, Mattila K, Nieminen MS, Huttunen JK, Leinonen M, Ekman MR et al. Serological evidence of an association of a novel chlamydia, TWAR with chronic coronary disease and acute myocardial infarction. Lancet 1988;2:983-6.
8. Blasi F, Cosentini R, Raccanelli R, Massari FM, Arosio C, Tarsia P et al. A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest 1997;112:309-12.
9. Thom DH, Graystone JT, Siscovik DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992;268:68-72.
10. Cook PJ, Honeybourne D, Lip G, Beevers G, Wise R, Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia. Stroke 1998;29:404-10.
11. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 2000;321:208-13.
12. Ridker PM, Kundsin RB, Stampfer MJ, Poulin S, Hennekens CH. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation 1999;99:1161-4.
13. Wald NJ, Law MR, Morris K, Zhou X, Wong Y, Ward ME. Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study. BMJ 2000;321:204-7.
14. Campbell LA, O'Brien ER, Cappucio AL, Kuo C-C, Wang S-P, Stewart D et al. Detection of Chlamydia pneumoniae (TWAR) in human atherectomy tissues. J Infect Dis 1995;172:585-8.
15. Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Lee MJ et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995;92:3397-400.
16. Maass M, Bartels C, Engel PM, Mamat U, Sievers HH. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 1998;31:827-32.
17. Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis: the Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med 1996;125:979-82.
18. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997;350:404-7.
19. Gupta S, Leatham EW, Carrington M, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997;96:404-7.
20. Anderson JL, Muhlestein JB, Carlquist J, Allen A, Trehan S, Nielson C et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. Circulation 1999;99:1540-7.
21. Diez RA, Tilz GP, Zangerle R, Baier BG, Wachter H, Fuchs D. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Hematol 1995;54:1-8.
22. Axelsson L, Bergenfeldt M, Ohlsson K. Studies of the release and turnover of a human lipocalin. Scand J Clin Lab Invest 1995;55:577-88.
23. Kelly RA, Smith TW. Cytokines and cardiac contractile function. Circulation 1997;95:778-81.
24. Gryglewski RJ, Botting RM, Vane JR. Mediators produced by the endothelial cell. Hypertension 1998;12:530-48.
25. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
26. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057-8.
27. Radomski MW, Moncada S. Biological role of nitric oxide in platelet function. In: Moncada S, Higgs EA, Berrazueta JR, editors. Clinical relevance of nitric oxide in the cardiovascular system. Madrid: EDICOMPLET; 1991.p.45-56.
28. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y et al. A novel potent vasoconstrictor produced by vascular endothelial cells. Nature 1988;332:411-5.
29. Ikeda U, Yamamoto K, Maeda Y, Shimpo M, Kanbe T, Shimada K. Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells. Hypertension 1997;29:65-9.
30. Lerman A, Holmes DR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 1995;92:2426-8.
31. Elneihoum AM, Falke P, Axelsson L, Lundberg E, Lindgärde F, Ohlsson K. Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischaemic cerebrovascular diseases. Stroke 1996;27:1734-8.
32. Tatzber F, Rabl H, Koriska K, Erhart U, Puhl U, Waeg G et al. Elevated serum neopterin levels in atherosclerosis. Atherosclerosis 1991;89:203-8.
33. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-41.
34. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
35. Vita JA, Treasure CB, Nabel EG, McLenacham LM, Fish RD, Yeung AC et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491-7.
36. Jacobsson L. Common rheumatic complaints, Thesis. Lund University, Sweden; 1991.
37. Jeppsson J-O, Jerntorp P, Sundkist G, Englund H, Nylund V. Measurement of haemoglobin A1c by a new lipid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 1986;32:1867-72.
38. Burstein M, Scholnick H, Morfin R. Rapid method for isolation of proteins from human serum by precipitation with polyanions. J Lipid Res 1970;11:583-95.
39. Axelsson L, Bergenfeldt M, Ohlsson K. Studies of the release and turnover of a human neutrophil lipocalin. Scand J Clin Lab Invest 1995;55:577-88.
40. Ohlsson K, Linder C, Lundberg E, Axelsson L. Release of cytokines and proteases from human peripheral blood mononuclear and polymorphonuclear cells following phagosytosis and LPS stimulation. Scand J Clin Lab Invest 1996;56:461-70.
41. Anwaar I, Gottsäter A, Hedblad B, Ohlsson K, Mattiasson I, Lindgärde F. Endothelial-derived vasoactive factors and leukocyte-derived inflammatory mediators in subjects with asymptomatic atherosclerosis. Angiology 1998;49:957-66.
42. Persson K, Trehane J. Diagnosis of infection caused by Chlamydia pneumoniae (strain TWAR) in patients with "ornithosis" in Southern Sweden 1981-1987. Scand J Infect Dis 1989;21:675-9.
43. Wong Y-K, Gallager PJ, Ward ME. Chlamydia pneumoniae and atherosclerosis. Heart 1999;81:232-8.
44. Anwaar I, Gottsäter A, Ohlsson K, Lindgärde F, Mattiasson I. Increasing levels of leukocyte-derived inflammatory mediators in plasma and cAMP in platelets during follow-up after acute cerebral ischemia. Cerebrovasc Dis 1998;8:310-7.
45. Anwaar I, Gottsäter A, Lindgärde F, Mattiasson I. Increasing plasma neopterin and persistent plasma endothelin during follow-up after acute cerebral ischemia. Angiology 1999;50:127-34.
46. Strachan P. Relation of Clamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study. BMJ 1999;318:1035-40.
47. Einarsson S, Sigurdsson HK, Magnusdottir SD, Erlendsdottir H, Briem H, Gudmundsson S. Age specific prevalence of antibodies against Chlamydia pneumoniae in Iceland. Scand J Infect Dis 1994;26:393-7.
48. Kanamoto Y, Ouchi K, Mizui M, Ushio M, Usui T. Prevalence of antibody to Chlamydia Pneumoniae TWAR in Japan. J Clin Microbiol 1991;29:816-8.
49. Karvonen M, Tuomiletho J, Pitkainemi J, Naukkarinen A, Saikku P. Chlamydia pneumoniae IgG antibody prevalence in South Western and Eastern Finland in 1982 and 1987. Int J Epidemiol 1994;23:176-84.
50. Grayston JT, Mordhorst C, Bruu AL. Countrywide epidemics of Chlamydia pneumoniae, strain TWAR, in Scandinavia, 1981-1983. J Infect Dis 1992;15:757-63.